Volume 27; Issue 6

Main
Leukemia
Volume 27; Issue 6

Leukemia

Volume 27; Issue 6

1

Azacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic stem cell transplantation

Schroeder, T, Czibere, A, Platzbecker, U, Bug, G, Uharek, L, Luft, T, Giagounidis, A, Zohren, F, Bruns, I, Wolschke, C, Rieger, K, Fenk, R, Germing, U, Haas, R, Kröger, N, Kobbe, G

Journal:

Year:

2013

Language:

english

File:

PDF, 435 KB

english, 2013

2

Nurse-like cells control the activity of chronic lymphocytic leukemia B cells via galectin-1

Croci, D O, Morande, P E, Dergan-Dylon, S, Borge, M, Toscano, M A, Stupirski, J C, Bezares, R F, Avalos, J S, Narbaitz, M, Gamberale, R, Rabinovich, G A, Giordano, M

Journal:

Year:

2013

Language:

english

File:

PDF, 1.81 MB

english, 2013

3

SETBP1 mutations in 658 patients with myelodysplastic syndromes, chronic myelomonocytic leukemia and secondary acute myeloid leukemias

Damm, F, Itzykson, R, Kosmider, O, Droin, N, Renneville, A, Chesnais, V, Gelsi-Boyer, V, de Botton, S, Vey, N, Preudhomme, C, Clavert, A, Delabesse, E, Park, S, Birnbaum, D, Fontenay, M, Bernard, O A,

Journal:

Year:

2013

Language:

english

File:

PDF, 274 KB

english, 2013

4

ATRA and the specific RARα agonist, NRX195183, have opposing effects on the clonogenicity of pre-leukemic murine AML1-ETO bone marrow cells

Chee, L C Y, Hendy, J, Purton, L E, McArthur, G A

Journal:

Year:

2013

Language:

english

File:

PDF, 2.80 MB

english, 2013

5

In focus: MLL-rearranged leukemia

de Boer, J, Walf-Vorderwülbecke, V, Williams, O

Journal:

Year:

2013

Language:

english

File:

PDF, 218 KB

english, 2013

6

Randomized comparison of prophylactic and minimal residual disease-triggered imatinib after allogeneic stem cell transplantation for BCR–ABL1-positive acute lymphoblastic leukemia

Pfeifer, H, Wassmann, B, Bethge, W, Dengler, J, Bornhäuser, M, Stadler, M, Beelen, D, Vucinic, V, Burmeister, T, Stelljes, M, Faul, C, Dreger, P, Kiani, A, Schäfer-Eckart, K, Schwerdtfeger, R, Lange,

Journal:

Year:

2013

Language:

english

File:

PDF, 729 KB

english, 2013

7

Safety and efficacy of CYT387, a JAK1 and JAK2 inhibitor, in myelofibrosis

Pardanani, A, Laborde, R R, Lasho, T L, Finke, C, Begna, K, Al-Kali, A, Hogan, W J, Litzow, M R, Leontovich, A, Kowalski, M, Tefferi, A

Journal:

Year:

2013

Language:

english

File:

PDF, 510 KB

english, 2013

8

HDAC inhibition by SNDX-275 (Entinostat) restores expression of silenced leukemia-associated transcription factors Nur77 and Nor1 and of key pro-apoptotic proteins in AML

Zhou, L, Ruvolo, V R, McQueen, T, Chen, W, Samudio, I J, Conneely, O, Konopleva, M, Andreeff, M

Journal:

Year:

2013

Language:

english

File:

PDF, 1.59 MB

english, 2013

9

AKT collaborates with ERG and Gata1s to dysregulate megakaryopoiesis and promote AMKL

Stankiewicz, M J, Crispino, J D

Journal:

Year:

2013

Language:

english

File:

PDF, 3.23 MB

english, 2013

10

Myelofibrosis, JAK2 inhibitors and erythropoiesis

Vainchenker, W, Favale, F

Journal:

Year:

2013

Language:

english

File:

PDF, 339 KB

english, 2013

11

Macrophage and NK-mediated killing of precursor-B acute lymphoblastic leukemia cells targeted with a-fucosylated anti-CD19 humanized antibodies

Matlawska-Wasowska, K, Ward, E, Stevens, S, Wang, Y, Herbst, R, Winter, S S, Wilson, B S

Journal:

Year:

2013

Language:

english

File:

PDF, 2.81 MB

english, 2013

12

Clonal diversity of recurrently mutated genes in myelodysplastic syndromes

Walter, M J, Shen, D, Shao, J, Ding, L, White, B S, Kandoth, C, Miller, C A, Niu, B, McLellan, M D, Dees, N D, Fulton, R, Elliot, K, Heath, S, Grillot, M, Westervelt, P, Link, D C, DiPersio, J F, Mard

Journal:

Year:

2013

Language:

english

File:

PDF, 2.91 MB

english, 2013

13

Peripheral artery occlusive disease in chronic phase chronic myeloid leukemia patients treated with nilotinib or imatinib

Kim, T D, Rea, D, Schwarz, M, Grille, P, Nicolini, F E, Rosti, G, Levato, L, Giles, F J, Dombret, H, Mirault, T, Labussière, H, Lindhorst, R, Haverkamp, W, Buschmann, I, Dörken, B, le Coutre, P D

Journal:

Year:

2013

Language:

english

File:

PDF, 249 KB

english, 2013

14

Low GFI1 expression in white blood cells of CP–CML patients at diagnosis is strongly associated with subsequent blastic transformation

Kok, C H, Watkins, D B, Leclercq, T, D'Andrea, R J, Hughes, T P, White, D L

Journal:

Year:

2013

Language:

english

File:

PDF, 364 KB

english, 2013

15

A novel recurrent AML1–ETO fusion: tight in vivo association with BCR–ABL1

Solari, L, Bauer, T, Dicker, F, Haferlach, C, Grießhammer, M, Schnittger, S, Becker, H, Lübbert, M

Journal:

Year:

2013

Language:

english

File:

PDF, 434 KB

english, 2013

16

γδT cells elicited by CMV reactivation after allo-SCT cross-recognize CMV and leukemia

Scheper, W, van Dorp, S, Kersting, S, Pietersma, F, Lindemans, C, Hol, S, Heijhuurs, S, Sebestyen, Z, Gründer, C, Marcu-Malina, V, Marchant, A, Donner, C, Plachter, B, Vermijlen, D, van Baarle, D, Kub

Journal:

Year:

2013

Language:

english

File:

PDF, 3.12 MB

english, 2013

17

Genome-wide profiling reveals epigenetic inactivation of the PU.1 pathway by histone H3 lysine 27 trimethylation in cytogenetically normal myelodysplastic syndrome

Cheng, J X, Anastasi, J, Watanabe, K, Kleinbrink, E L, Grimley, E, Knibbs, R, Shen, Q J, Vardiman, J W

Journal:

Year:

2013

Language:

english

File:

PDF, 2.57 MB

english, 2013

18

Phase II study of nilotinib in patients with relapsed or refractory Philadelphia chromosome—positive acute lymphoblastic leukemia

Ottmann, O G, Larson, R A, Kantarjian, H M, le Coutre, P D, Baccarani, M, Hochhaus, A, Kim, D W, Fan, X, Novick, S, Giles, F J

Journal:

Year:

2013

Language:

english

File:

PDF, 189 KB

english, 2013

19

Rates of peripheral arterial occlusive disease in patients with chronic myeloid leukemia in the chronic phase treated with imatinib, nilotinib, or non-tyrosine kinase therapy: a retrospective cohort analysis

Giles, F J, Mauro, M J, Hong, F, Ortmann, C-E, McNeill, C, Woodman, R C, Hochhaus, A, le Coutre, P D, Saglio, G

Journal:

Year:

2013

Language:

english

File:

PDF, 253 KB

english, 2013

20

Inhibition of intracellular dipeptidyl peptidases 8 and 9 enhances parthenolide’s anti-leukemic activity

Spagnuolo, P A, Hurren, R, Gronda, M, MacLean, N, Datti, A, Basheer, A, Lin, F-H, Wang, X, Wrana, J, Schimmer, A D

Journal:

Year:

2013

Language:

english

File:

PDF, 1.34 MB

english, 2013

21

Defined, serum-free conditions for in vitro culture of primary human T-ALL blasts

Yost, A J, Shevchuk, O O, Gooch, R, Gusscott, S, You, M J, Ince, T A, Aster, J C, Weng, A P

Journal:

Year:

2013

Language:

english

File:

PDF, 926 KB

english, 2013

22

Multiple mechanisms deregulate EZH2 and histone H3 lysine 27 epigenetic changes in myeloid malignancies

Khan, S N, Jankowska, A M, Mahfouz, R, Dunbar, A J, Sugimoto, Y, Hosono, N, Hu, Z, Cheriyath, V, Vatolin, S, Przychodzen, B, Reu, F J, Saunthararajah, Y, O'Keefe, C, Sekeres, M A, List, A F, Moliterno

Journal:

Year:

2013

Language:

english

File:

PDF, 1.31 MB

english, 2013

23

Lenalidomide-induced upregulation of CXCR4 in CD34+ hematopoietic cells, a potential mechanism of decreased hematopoietic progenitor mobilization

Li, S, Fu, J, Ma, H, Mapara, M Y, Lentzsch, S

Journal:

Year:

2013

Language:

english

File:

PDF, 1.16 MB

english, 2013

24

MCL1 is deregulated in subgroups of diffuse large B-cell lymphoma

Wenzel, S-S, Grau, M, Mavis, C, Hailfinger, S, Wolf, A, Madle, H, Deeb, G, Dörken, B, Thome, M, Lenz, P, Dirnhofer, S, Hernandez-Ilizaliturri, F J, Tzankov, A, Lenz, G

Journal:

Year:

2013

Language:

english

File:

PDF, 1.49 MB

english, 2013

25

Comparison of outcomes between autologous and allogeneic hematopoietic stem cell transplantation for peripheral T-cell lymphomas with central review of pathology

Journal:

Year:

2013

Language:

english

File:

PDF, 235 KB

english, 2013

26

A response-adjusted PET-based transplantation strategy in primary resistant and relapsed Hodgkin Lymphoma

Thomson, K J, Kayani, I, Ardeshna, K, Morris, E C, Hough, R, Virchis, A, Goldstone, A H, Linch, D C, Peggs, K S

Journal:

Year:

2013

Language:

english

File:

PDF, 231 KB

english, 2013

27

Secondary mutations in t(4;11) leukemia patients

Prelle, C, Bursen, A, Dingermann, T, Marschalek, R

Journal:

Year:

2013

Language:

english

File:

PDF, 1.00 MB

english, 2013

28

Sequential combination of azacitidine and lenalidomide in del(5q) higher-risk myelodysplastic syndromes or acute myeloid leukemia: a phase I study

Platzbecker, U, Braulke, F, Kündgen, A, Götze, K, Bug, G, Schönefeldt, C, Shirneshan, K, Röllig, C, Bornhäuser, M, Naumann, R, Neesen, J, Giagounidis, A, Hofmann, W-K, Ehninger, G, Germing, U, Haase,

Journal:

Year:

2013

Language:

english

File:

PDF, 636 KB

english, 2013

29

Risk of acute leukemia and myelodysplastic syndromes in patients with monoclonal gammopathy of undetermined significance (MGUS): a population-based study of 17 315 patients

Roeker, L E, Larson, D R, Kyle, R A, Kumar, S, Dispenzieri, A, Rajkumar, S V

Journal:

Year:

2013

Language:

english

File:

PDF, 149 KB

english, 2013

30

Long-term outcome of anemic lower-risk myelodysplastic syndromes without 5q deletion refractory to or relapsing after erythropoiesis-stimulating agents

Kelaidi, C, Park, S, Sapena, R, Beyne-Rauzy, O, Coiteux, V, Vey, N, Stamatoullas, A, Choufi, B, Delaunay, J, Gourin, M-P, Cheze, S, Ravoet, C, Ferrant, A, Escoffre-Barbe, M, Aljassem, L, Raffoux, E, I

Journal:

Year:

2013

Language:

english

File:

PDF, 615 KB

english, 2013

31

Acute lymphoblastic leukemia associated with RCSD1–ABL1 novel fusion gene has a distinct gene expression profile from BCR–ABL1 fusion

De Braekeleer, E, Douet-Guilbert, N, Guardiola, P, Rowe, D, Mustjoki, S, Zamecnikova, A, Al Bahar, S, Jaramillo, G, Berthou, C, Bown, N, Porkka, K, Ochoa, C, De Braekeleer, M

Journal:

Year:

2013

Language:

english

File:

PDF, 168 KB

english, 2013

32

Bivalent promoter marks and a latent enhancer may prime the leukaemia oncogene LMO1 for ectopic expression in T-cell leukaemia

Oram, S H, Thoms, J, Sive, J I, Calero-Nieto, F J, Kinston, S J, Schütte, J, Knezevic, K, Lock, R B, Pimanda, J E, Göttgens, B

Journal:

Year:

2013

Language:

english

File:

PDF, 1.90 MB

english, 2013

33

Direct binding of Grb2 has an important role in the development of myeloproliferative disease induced by ETV6/FLT3

Chonabayashi, K, Hishizawa, M, Kawamata, S, Nagai, Y, Ohno, T, Ishikawa, T, Uchiyama, T, Takaori-Kondo, A

Journal:

Year:

2013

Language:

english

File:

PDF, 1.33 MB

english, 2013

34

Increased circulating IL-2Rα (CD25) predicts poor outcome in both indolent and aggressive forms of mastocytosis: a comprehensive cytokine–phenotype study

Pardanani, A, Finke, C, Abdelrahman, R A, Lasho, T L, Hanson, C A, Tefferi, A

Journal:

Year:

2013

Language:

english

File:

PDF, 235 KB

english, 2013

35

The secondary FLT3-ITD F691L mutation induces resistance to AC220 in FLT3-ITD+ AML but retains in vitro sensitivity to PKC412 and Sunitinib

Albers, C, Leischner, H, Verbeek, M, Yu, C, Illert, A L, Peschel, C, von Bubnoff, N, Duyster, J

Journal:

Year:

2013

Language:

english

File:

PDF, 942 KB

english, 2013

36

Impairing MLL-fusion gene-mediated transformation by dissecting critical interactions with the lens epithelium-derived growth factor (LEDGF/p75)

Méreau, H, De Rijck, J, Čermáková, K, Kutz, A, Juge, S, Demeulemeester, J, Gijsbers, R, Christ, F, Debyser, Z, Schwaller, J

Journal:

Year:

2013

Language:

english

File:

PDF, 1.86 MB

english, 2013